Studies have shown that Wegovy, a brand name of semaglutide, is effective in helping people lose weight, with a significant proportion of them achieving at least a 5 per cent weight loss.
Wegovy is a brand name for semaglutide, a GLP-1 analogue. It acts in the same way as GLP-1 and, among other things, appears to regulate appetite by increasing a person’s feelings of fullness, while reducing their food intake, hunger and cravings.
The National Institute for Health and Care Excellence issued guidelines this year recommending Wegovy be prescribed to people who have a particular BMI and at least one weight-related health condition, such as diabetes, high blood pressure, abnormal levels of fats in the blood, breathing problems during sleep called “obstructive sleep apnoea” or a history of heart attack, stroke or blood vessel problems.
Studies have shown that Wegovy is effective in helping people lose weight, with a significant proportion of them achieving at least a 5 per cent weight loss. The amount of weight you lose on Wegovy would depend on your personal circumstances, the support you receive and how long you are on the medication for, experts say.people on the maximum dose lost 12 per cent more of their body weight compared to those who were not on the medication.
Crucially, both groups received advice to reduce their calorie intake, and increase their physical activity levels, which shows the importance of making those changes to get the best out of any weight-loss medications. Like other weight loss medications, there is evidence of weight regain when people stop using Wegovy so it is important to continue to receive support in making changes to your diet and physical activity levels. Nice recommends taking the drug for a maximum of two years.
Danmark Seneste Nyt, Danmark Overskrifter
Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.
Weight-loss jab Wegovy to be available in UK from todayThe manufacturer of the drug semaglutide expects demand to outstrip supply
Læs mere »
'Game changer' Wegovy weight loss jab now available on the NHSWegovy, which was supposed to be rolled out on the NHS earlier this year, is being given a 'controlled and limited launch' due to ongoing supply problems, according to its manufacturers
Læs mere »
Wegovy weight-loss jab to launch in the UKThe drug is in short supply but a proportion has been allocated to specialist NHS services
Læs mere »
Wegovy weight-loss jab to launch in the UKThe drug is in short supply but a proportion has been allocated to specialist NHS services
Læs mere »
Weight-loss jab Wegovy made available on NHS as manufacturer says stocks are limitedWegovy, also known as semaglutide, can now be prescribed by NHS weight management services, with up to 50,000 patients set to benefit.
Læs mere »
Weight-loss jab Wegovy launched in UK today via NHS and some private doctorsSome NHS patients could be prescribed weight loss jab Wegovy as part of a 'controlled and limited launch'.
Læs mere »